logo
Plus   Neg
Share
Email

Just - Evotec Grants MSD Access To J.POD(R) Facility - Quick Facts

Just - Evotec Biologics Inc., wholly owned by Evotec SE (EVTCY.PK,EVOTF.PK), has agreed to grant Merck & Co., Inc. access to capacity in the J.POD(R) facility in Redmond, Washington, which is currently under construction. This agreement gives MSD access to manufacturing capacity, which is compatible with the manufacturing platform co-developed by MSD and Just - Evotec Biologics under a previous agreement announced in 2015. The collaboration deal includes an upfront payment of $15 million, and near term milestone payments.

Just - Evotec Biologics is a unique platform company that integrates the design, engineering, development, and manufacture of biologics. J.POD(R) (manufacturing and plant design) is an integral part of Just - Evotec Biologics' J.DESIGN platform that combines data analytics and machine learning.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Video streaming giant Netflix said it will donate 1 million euros to Audiens, the social protection group of the French cultural sector, to help launch a COVID-19 emergency relief fund to support workers in the French television and cinema industry. Netflix and Audiens said they have created the new COVID-19 Film and TV Emergency Relief Fund to help the hardest hit workers in the industry. Major U.S. retail container ports are estimated to report a five-year low for imports in March as consumer demand has been impacted with millions of Americans out of work amid the coronavirus (COVID-19) outbreak, according to a report by the National Retail Federation or NRF. The U.S. Food and Drug Administration has issued warning letters to three sellers of fraudulent COVID-19 products. There are currently no approved preventatives or treatments for COVID-19, the FDA said in a statement.
Follow RTT
>